MALLINCKRODT

mallinckrodt-logo

Their evolution as a company starts now, and they are poised for an exciting future. Their core strengths provide the impetus for future success, including skills in the acquisition and management of highly regulated raw materials; strong regulatory knowledge, reputation, and relationships; distinctive manufacturing and logistics skills where vertical integration is an advantage; expertise in specialized chemistry, development, and formulation; and global commercial reach.
#People #Financial #Event #Website #More

MALLINCKRODT

Social Links:

linkedin

Linkedin

Industry:
Biotechnology

Founded:
1867-01-01

Address:
Blanchardstown, Dublin, Ireland

Country:
Ireland

Website Url:
http://www.mallinckrodt.com

Total Employee:
5001+

Status:
Active

Contact:
+1 314-654-2000

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Content Delivery Network



Current Advisors List

david-carlucci_image

David Carlucci Member of Board of Directors @ Mallinckrodt
Board_member

melvin-booth_image

Melvin Booth Chairman of the Board of Directors @ Mallinckrodt
Board_member

Current Employees Featured

ryan-magee_image

Ryan Magee
Ryan Magee Global Device Engineering Director of Validation and Engineering Services @ Mallinckrodt
Global Device Engineering Director of Validation and Engineering Services
2019-07-01

jim-shortt_image

Jim Shortt
Jim Shortt Engineering Manager @ Mallinckrodt
Engineering Manager
2016-07-01

not_available_image

Emil Mallinckrodt
Emil Mallinckrodt Founder @ Mallinckrodt
Founder

mark-trudeau_image

Mark Trudeau
Mark Trudeau CEO @ Mallinckrodt
CEO

matt-harbaugh_image

Matt Harbaugh
Matt Harbaugh CFO @ Mallinckrodt
CFO

oliver-fay_image

Oliver Fay
Oliver Fay Project Manager, ARD Program Management @ Mallinckrodt
Project Manager, ARD Program Management

Founder


not_available_image

Emil Mallinckrodt

Stock Details


Company's stock symbol is NYSE:MNK

Acquisitions List

Date Company Article Price
2017-12-26 Sucampo Pharmaceuticals Sucampo Pharmaceuticals acquired by Mallinckrodt 1.2 B USD
2017-11-02 Ocera Therapeutics Ocera Therapeutics acquired by Mallinckrodt 42 M USD
2017-08-04 InfaCare Pharmaceutical InfaCare Pharmaceutical acquired by Mallinckrodt N/A
2016-08-10 Stratatech Corporation Stratatech Corporation acquired by Mallinckrodt N/A
2015-08-10 Therakos Therakos acquired by Mallinckrodt 1.33 B USD
2015-03-05 Ikaria Ikaria acquired by Mallinckrodt 2.3 B USD
2014-04-07 Questcor Pharmaceuticals Questcor Pharmaceuticals acquired by Mallinckrodt N/A
2014-02-11 Cadence Pharmaceuticals Cadence Pharmaceuticals acquired by Mallinckrodt N/A
2012-09-24 CNS Therapeutics (Old) CNS Therapeutics (Old) acquired by Mallinckrodt 100 M USD
1997-07-24 Nellcor Puritan Bennett Nellcor Puritan Bennett acquired by Mallinckrodt 1.81 B USD

Investments List

Date Company Article Money raised
2019-07-18 Silence Therapeutics Mallinckrodt investment in Post-IPO Equity - Silence Therapeutics 5 M USD

Newest Events participated

american-association-of-nurse-anesthetists-aana-2017-annual-congress_event_image Participated in American Association of Nurse Anesthetists (AANA) 2017 Annual Congress on 2017-09-08 as exhibitor

Official Site Inspections

http://www.mallinckrodt.com Semrush global rank: 1.88 M Semrush visits lastest month: 11.69 K

  • Host name: 45.60.240.79
  • IP address: 45.60.240.79
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Mallinckrodt" on Search Engine